focus -WSS

focus

author：knowledge 2025-10-01 06:01:12 - browse：58

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Thursday released a new accounting of artificial intelligence tools cleared for use in health care, adding scores of new products designed to reshape care in several areas of medicine.

The update included 171 new products that use artificial intelligence and machine learning, including 155 authorized since August of 2022. The agency’s data indicate that, after a lull during the Covid-19 pandemic, the number of authorized devices in 2023 is expected to increase by more than 30% over the prior year.

The list of AI devices was first published after a STAT investigation reported that the FDA had failed to keep the public informed on its regulation of AI devices, or crucial details on the tests undertaken to prove their safety and effectiveness. The summary documents that describe new AI devices often fail to break out the demographics of the patients they were tested on, or where the testing took place, which makes it difficult for clinicians and patients to understand their potential biases and weaknesses.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Eli Lilly’s Zepbound improved liver scarring in mid

hotspot

knowledge

WSS

CMS got Medicare Advantage quality rating wrong, judge rules

Take antibiotics after sex, CDC recommends for certain risk groups

Fight over Supreme Court dialysis ruling puts kidney patients at risk

Readers discuss the intersection of pregnancy and addiction

Health care court cases: Humana, Sutter, Novant

STAT wants to know your pick for a great summer read or listen

focus

focus

leisure time

United colonoscopy coverage change 'may cost lives,' doctors say

Cigna wins case to block Amy Bricker's move to CVS

BioMarin wins approval for gene therapy to treat hemophilia A

New report analyzes digital physical therapy solutions' effectiveness

Anesthesiologist group: stop taking Ozempic before surgery

Deposition: Sackler embraced plan to conceal OxyContin’s strength

Dobbs anniversary: the lost opportunity of abortion as health care

Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

Guidelines to prevent youth baseball injuries need more muscle

Curing rare childhood diseases will falter unless Congress steps up

knowledge

5 takeaways from STAT's examination of Zynex Medical

ASCO Daily Recap: CAR

Novartis is flashing warning signs about its newly acquired myelofibrosis drug

Curing rare childhood diseases will falter unless Congress steps up

The most pressing bird flu mysteries scientists want answered

NIH tests clinical research in primary care with $30 million program

knowledge

hotspot

knowledge

hotspot